Drugs / MK-1972
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01353898 | Jun 2011 → Jan 2012 | HIV infectious disease | Merck Sharp & Dohme LLC | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK-1972 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01353898 ↗ |
| Route | Oral | “will be given orally” NCT01353898 ↗ |